Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial-Reference-Cited by-同舟云学术

Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial

Published:2021-09 Issue:9 Volume:22 Page:1322-1332
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Yang Wenyu,Cai Jiaoyang,Shen Shuhong,Gao Ju,Yu Jie,Hu Shaoyan,Jiang Hua,Fang Yongjun,Liang Changda,Ju Xiuli,Wu Xuedong,Zhai Xiaowen,Tian Xin,Wang Ningling,Liu Aiguo,Jiang Hui,Jin Runming,Sun Lirong,Yang Minghua,Leung Alex W K,Pan Kaili,Zhang Yingchi,Chen Jing,Zhu Yiping,Zhang Hui,Li Chunfu,Yang Jun J,Cheng Cheng,Li Chi-Kong,Tang Jingyan,Zhu Xiaofan,Pui Ching-Hon

Funder

NCI

ALSAC

Foundation for Innovative Research Groups of the National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia—an individual patient data meta-analysis involving 5659 children;Eden;Br J Haematol,2010

2. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group;Bostrom;Blood,2003

3. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial;Mitchell;Br J Haematol,2005